|
Statistical power estimation for a time-dependent covariate in Cox (proportional hazards) regression
|
|
0
|
1983
|
April 19, 2022
|
|
Outcome dispersion and reduction of outliers as a primary outcome in clinical RCT?
|
|
3
|
2444
|
February 24, 2022
|
|
RCT - baseline measures and group x time interaction without main effect for group?
|
|
6
|
6398
|
January 1, 2022
|
|
Some help needed regarding how to conduct an external validation study
|
|
0
|
2188
|
December 23, 2021
|
|
Step Wedge study design with continuous outcome in the Covid era
|
|
7
|
3737
|
November 28, 2021
|
|
Sample Size for Bland Altman plot
|
|
1
|
5958
|
October 17, 2021
|
|
Sample size calculations - exact vs. approximate
|
|
0
|
2920
|
October 6, 2021
|
|
Sample size determination for observational studies
|
|
6
|
14937
|
October 4, 2021
|
|
Concrete examples of the pre-planned analysis going wrong
|
|
16
|
4872
|
August 24, 2021
|
|
Early phase dose finding studies - inviting perspectives on 3+3 versus dose titration
|
|
8
|
13319
|
July 24, 2021
|
|
Designing numerical stimuli
|
|
0
|
2790
|
July 7, 2021
|
|
Default Using R package to implement Bayesian phase I/II dose-finding design for three outcomes
|
|
10
|
4345
|
June 10, 2021
|
|
Bootstrap and prior distribution method for self-controlled case series design
|
|
0
|
2375
|
June 9, 2021
|
|
Fully sequential Bayesian clinical trial design for in-hospital treatment of COVID-19
|
|
23
|
12797
|
June 7, 2021
|
|
Debunking myths: intention to treat , missing follow-up and imputation
|
|
6
|
4770
|
March 15, 2021
|
|
Sample size requirements for a proportional odds model
|
|
7
|
7639
|
March 15, 2021
|
|
Devising a database
|
|
7
|
5546
|
February 23, 2021
|
|
Value stream mapping - numbers needed
|
|
0
|
3092
|
February 8, 2021
|
|
Power Analysis for 3 Groups and 3 Measures
|
|
1
|
4004
|
February 7, 2021
|
|
DAGs for Bayesian hierarchical models?
|
|
4
|
8537
|
January 8, 2021
|
|
Sample size estimation
|
|
6
|
6179
|
November 14, 2020
|
|
RCT trials for COVID study vaccines
|
|
0
|
3253
|
October 24, 2020
|
|
"Open label, double-masked trial"
|
|
0
|
3720
|
October 13, 2020
|
|
Bayesian solution for study designs
|
|
0
|
3306
|
September 24, 2020
|
|
Factorial design - dropping factors and conditions
|
|
1
|
2611
|
September 1, 2020
|
|
Re-starting a Bayesian group sequential design trial after stopping it
|
|
4
|
3188
|
August 11, 2020
|
|
Stratification, block-randomization, etc
|
|
6
|
7332
|
August 4, 2020
|
|
Multiplicity in AIM-NIVO trial, uncontrolled by statistical discipline
|
|
0
|
2857
|
June 12, 2020
|
|
Seeking advice on Ethics and Efficiency of testing safety in a curative setting?
|
|
4
|
3640
|
May 31, 2020
|
|
When is censoring too high?
|
|
11
|
21846
|
May 28, 2020
|